SCR-LIP-000304 · Claim · machine-readable JSON →

This review of Dercum's disease describes inflammatory and pain mechanisms overlapping with lipedema, including serum multiplex immunoassay of 37 cytokines identifying 22 present with significantly elevated IL-11, IL-28A, and IL-29, near-infrared fluorescence imaging showing abnormal fibrotic dilated lymphatic vessels, M1-like pro-inflammatory macrophage predominance, mast cell activation with substance P-induced release of histamine, TNF-alpha, and IL-1beta sensitizing nociceptors, and proposes lipedema as an estrogen-sensitive adipose disorder possibly initiated by caveolin-1 dysfunction.

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
very low (GRADE)
Evidence
1 source(s)
Dates
2026-05-31 → 2026-05-31

Structured evidence, machine-compiled — not a verdict.

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31

Evidence over time

2025The Molecular Mechanisms Underlying Dercum’s Disease: Exploring the Intersection of Obesity, Pain, and Inflammation — Reytor-González et al. (2025) · consistent

Evidence (1)

Context (PECO)

Populationpatients with Dercum's disease and lipedema
Conditionlipedema
Exposureinflammatory cytokine profiling and lymphatic imaging
Outcomecytokine elevation, lymphatic abnormalities, pain mechanisms
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log